Researchers from the Kessler Foundation will launch a new study investigating the effects of Tysabri (natalizumab) on cognitive fatigue — the type of fatigue that happens after strong mental concentration, such as in problem-solving — in people with relapsing-remitting multiple sclerosis (RRMS). Cognitive fatigue, which is very common in MS, is considered the most disturbing symptom of the disease by about 40% of patients, according to the Kessler Foundation. Despite this, there are few treatment…

You must be logged in to read/download the full post.